Matches in SemOpenAlex for { <https://semopenalex.org/work/W2082904314> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- W2082904314 endingPage "P02.127" @default.
- W2082904314 startingPage "P02.127" @default.
- W2082904314 abstract "Objective: To evaluate the role of Prolactin in MS pathogenesis. Background Hyperprolactinemia has been associated with different autoimmune diseases in humans. Moreover, increased levels of Prolactin have been found in experimental MS models and administration of prolactin antagonists suppressed disease. Design/Methods: Ninety-two patients with relapsing remitting MS were examined, fifty-eight during remission and 32 during exacerbations. Forty healthy age and gender-matched subjects served as controls. Prolactin, JAK2, Stat1, Stat3, Stat5, BAFF, and Bcl-2 were measured by ELISA. Prolactin receptor and IRF-1 expression were assessed using RT-PCR. Anti-MOG antibodies were measured by ELISPOT. Results: Prolactin levels were higher in MS subjects compared to controls (p= 0.01). However, no differences were found in men, and no association was found between disease activity and Prolactin levels. B and T cells isolated from both MS patients and controls expressed Prolactin receptor, which were upregulated by estrogens. B cells isolated from MS patients demonstrated higher JAK2/Stat pathway activation and IRF-1 expression. Likewise, B cells stimulated in vitro with Prolactin showed increased JAK2 and IRF-1 expression, and Stat protein phosphorylation. Anti-MOG antibodies, BAFF and Bcl-2 levels were significantly higher in MS patients compared to healthy subjects, findings reproduced by culturing CD19+, and CD19+CD5+ B cells in the presence of Prolactin. Moreover, prolactin antagonists blocked these effects, suggesting Prolactin may enhance autoreactive B cells survival. Finally, Prolactin induced CD40 expression on B cells, suggesting it may rescue autoreactive B cells, possibly through recruitment of T cell support. Conclusions: Prolactin can promote B cell autoreactivity in MS through different mechanisms, mediated by the JAK2/Stat pathway. Prolactin influence over the hormonal milieu may have implications on pathogenic immune responses in MS. Disclosure: Dr. Correale has received personal compensation for activities with Merck Serono Argentina, Biogen Idec, Novartis, and from Teva Neuroscience as a speaker. Dr. Farez has nothing to disclose. Dr. Ysrraelit has nothing to disclose." @default.
- W2082904314 created "2016-06-24" @default.
- W2082904314 creator A5014042438 @default.
- W2082904314 creator A5040699917 @default.
- W2082904314 creator A5047408530 @default.
- W2082904314 date "2012-04-22" @default.
- W2082904314 modified "2023-09-25" @default.
- W2082904314 title "The Role of Prolactin on B Cell Regulation in Multiple Sclerosis (P02.127)" @default.
- W2082904314 doi "https://doi.org/10.1212/wnl.78.1_meetingabstracts.p02.127" @default.
- W2082904314 hasPublicationYear "2012" @default.
- W2082904314 type Work @default.
- W2082904314 sameAs 2082904314 @default.
- W2082904314 citedByCount "0" @default.
- W2082904314 crossrefType "journal-article" @default.
- W2082904314 hasAuthorship W2082904314A5014042438 @default.
- W2082904314 hasAuthorship W2082904314A5040699917 @default.
- W2082904314 hasAuthorship W2082904314A5047408530 @default.
- W2082904314 hasConcept C126322002 @default.
- W2082904314 hasConcept C169760540 @default.
- W2082904314 hasConcept C203014093 @default.
- W2082904314 hasConcept C2779064019 @default.
- W2082904314 hasConcept C2780640218 @default.
- W2082904314 hasConcept C71315377 @default.
- W2082904314 hasConcept C71924100 @default.
- W2082904314 hasConcept C86803240 @default.
- W2082904314 hasConceptScore W2082904314C126322002 @default.
- W2082904314 hasConceptScore W2082904314C169760540 @default.
- W2082904314 hasConceptScore W2082904314C203014093 @default.
- W2082904314 hasConceptScore W2082904314C2779064019 @default.
- W2082904314 hasConceptScore W2082904314C2780640218 @default.
- W2082904314 hasConceptScore W2082904314C71315377 @default.
- W2082904314 hasConceptScore W2082904314C71924100 @default.
- W2082904314 hasConceptScore W2082904314C86803240 @default.
- W2082904314 hasIssue "Meeting Abstracts 1" @default.
- W2082904314 hasLocation W20829043141 @default.
- W2082904314 hasOpenAccess W2082904314 @default.
- W2082904314 hasPrimaryLocation W20829043141 @default.
- W2082904314 hasRelatedWork W1969888616 @default.
- W2082904314 hasRelatedWork W2096708063 @default.
- W2082904314 hasRelatedWork W2158330225 @default.
- W2082904314 hasRelatedWork W2160062436 @default.
- W2082904314 hasRelatedWork W2188624597 @default.
- W2082904314 hasRelatedWork W2323734028 @default.
- W2082904314 hasRelatedWork W2617222556 @default.
- W2082904314 hasRelatedWork W3130762070 @default.
- W2082904314 hasRelatedWork W4247304472 @default.
- W2082904314 hasRelatedWork W2740593323 @default.
- W2082904314 hasVolume "78" @default.
- W2082904314 isParatext "false" @default.
- W2082904314 isRetracted "false" @default.
- W2082904314 magId "2082904314" @default.
- W2082904314 workType "article" @default.